BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 21229994)

  • 21. Minimization of human relaxin-3 leading to high-affinity analogues with increased selectivity for relaxin-family peptide 3 receptor (RXFP3) over RXFP1.
    Shabanpoor F; Akhter Hossain M; Ryan PJ; Belgi A; Layfield S; Kocan M; Zhang S; Samuel CS; Gundlach AL; Bathgate RA; Separovic F; Wade JD
    J Med Chem; 2012 Feb; 55(4):1671-81. PubMed ID: 22257012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-144-3p targets relaxin/insulin-like family peptide receptor 1 (RXFP1) expression in lung fibroblasts from patients with idiopathic pulmonary fibrosis.
    Bahudhanapati H; Tan J; Dutta JA; Strock SB; Sembrat J; Àlvarez D; Rojas M; Jäger B; Prasse A; Zhang Y; Kass DJ
    J Biol Chem; 2019 Mar; 294(13):5008-5022. PubMed ID: 30709904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Matrix-Metallo-Proteinases and their tissue inhibitors in radiation-induced lung injury.
    Yang K; Palm J; König J; Seeland U; Rosenkranz S; Feiden W; Rübe C; Rübe CE
    Int J Radiat Biol; 2007 Oct; 83(10):665-76. PubMed ID: 17729161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. H2 relaxin is a biased ligand relative to H3 relaxin at the relaxin family peptide receptor 3 (RXFP3).
    van der Westhuizen ET; Christopoulos A; Sexton PM; Wade JD; Summers RJ
    Mol Pharmacol; 2010 May; 77(5):759-72. PubMed ID: 20159943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relaxin family peptide receptor 1 (RXFP1): An emerging player in human health and disease.
    Chen TY; Li X; Hung CH; Bahudhanapati H; Tan J; Kass DJ; Zhang Y
    Mol Genet Genomic Med; 2020 Apr; 8(4):e1194. PubMed ID: 32100955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of RXFP1 Is Decreased in Idiopathic Pulmonary Fibrosis. Implications for Relaxin-based Therapies.
    Tan J; Tedrow JR; Dutta JA; Juan-Guardela B; Nouraie M; Chu Y; Trejo Bittar H; Ramani K; Biswas PS; Veraldi KL; Kaminski N; Zhang Y; Kass DJ
    Am J Respir Crit Care Med; 2016 Dec; 194(11):1392-1402. PubMed ID: 27310652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Curcumin reduces cardiac fibrosis by inhibiting myofibroblast differentiation and decreasing transforming growth factor β1 and matrix metalloproteinase 9 / tissue inhibitor of metalloproteinase 1.
    Ma J; Ma SY; Ding CH
    Chin J Integr Med; 2017 May; 23(5):362-369. PubMed ID: 26956464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relaxin down-regulates renal fibroblast function and promotes matrix remodelling in vitro.
    Masterson R; Hewitson TD; Kelynack K; Martic M; Parry L; Bathgate R; Darby I; Becker G
    Nephrol Dial Transplant; 2004 Mar; 19(3):544-52. PubMed ID: 14767007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic effects of a small molecule agonist of the relaxin receptor ML290 in liver fibrosis.
    Kaftanovskaya EM; Ng HH; Soula M; Rivas B; Myhr C; Ho BA; Cervantes BA; Shupe TD; Devarasetty M; Hu X; Xu X; Patnaik S; Wilson KJ; Barnaeva E; Ferrer M; Southall NT; Marugan JJ; Bishop CE; Agoulnik IU; Agoulnik AI
    FASEB J; 2019 Nov; 33(11):12435-12446. PubMed ID: 31419161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serelaxin inhibits differentiation and fibrotic behaviors of cardiac fibroblasts by suppressing ALK-5/Smad2/3 signaling pathway.
    Wu XP; Wang HJ; Wang YL; Shen HR; Tan YZ
    Exp Cell Res; 2018 Jan; 362(1):17-27. PubMed ID: 28987540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered production of extra-cellular matrix components by muscle-derived Duchenne muscular dystrophy fibroblasts before and after TGF-beta1 treatment.
    Zanotti S; Gibertini S; Mora M
    Cell Tissue Res; 2010 Feb; 339(2):397-410. PubMed ID: 19902258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AT1R-AT2R-RXFP1 Functional Crosstalk in Myofibroblasts: Impact on the Therapeutic Targeting of Renal and Cardiac Fibrosis.
    Chow BSM; Kocan M; Shen M; Wang Y; Han L; Chew JY; Wang C; Bosnyak S; Mirabito-Colafella KM; Barsha G; Wigg B; Johnstone EKM; Hossain MA; Pfleger KDG; Denton KM; Widdop RE; Summers RJ; Bathgate RAD; Hewitson TD; Samuel CS
    J Am Soc Nephrol; 2019 Nov; 30(11):2191-2207. PubMed ID: 31511361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Notch3 Ameliorates Cardiac Fibrosis After Myocardial Infarction by Inhibiting the TGF-β1/Smad3 Pathway.
    Zhang M; Pan X; Zou Q; Xia Y; Chen J; Hao Q; Wang H; Sun D
    Cardiovasc Toxicol; 2016 Oct; 16(4):316-24. PubMed ID: 26487518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural Insights into the Activation of Human Relaxin Family Peptide Receptor 1 by Small-Molecule Agonists.
    Hu X; Myhr C; Huang Z; Xiao J; Barnaeva E; Ho BA; Agoulnik IU; Ferrer M; Marugan JJ; Southall N; Agoulnik AI
    Biochemistry; 2016 Mar; 55(12):1772-83. PubMed ID: 26866459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigations into the inhibitory effects of relaxin on renal myofibroblast differentiation.
    Samuel CS; Mookerjee I; Halls ML; Summers RJ; Chew E; Bathgate RA; Tregear GW; Hewitson TD
    Ann N Y Acad Sci; 2009 Apr; 1160():294-9. PubMed ID: 19416207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serelaxin alleviates cardiac fibrosis through inhibiting endothelial-to-mesenchymal transition via RXFP1.
    Wilhelmi T; Xu X; Tan X; Hulshoff MS; Maamari S; Sossalla S; Zeisberg M; Zeisberg EM
    Theranostics; 2020; 10(9):3905-3924. PubMed ID: 32226528
    [No Abstract]   [Full Text] [Related]  

  • 37. Characterizing relaxin receptor expression and exploring relaxin's effect on tissue remodeling/fibrosis in the human bladder.
    Diaz EC; Briggs M; Wen Y; Zhuang G; Wallace SL; Dobberfuhl AD; Kao CS; Chen BC
    BMC Urol; 2020 Apr; 20(1):44. PubMed ID: 32321501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diverse regulation of cardiac expression of relaxin receptor by α1- and β1-adrenoceptors.
    Moore XL; Su Y; Fan Y; Zhang YY; Woodcock EA; Dart AM; Du XJ
    Cardiovasc Drugs Ther; 2014 Jun; 28(3):221-8. PubMed ID: 24852484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relaxin-3: improved synthesis strategy and demonstration of its high-affinity interaction with the relaxin receptor LGR7 both in vitro and in vivo.
    Bathgate RA; Lin F; Hanson NF; Otvos L; Guidolin A; Giannakis C; Bastiras S; Layfield SL; Ferraro T; Ma S; Zhao C; Gundlach AL; Samuel CS; Tregear GW; Wade JD
    Biochemistry; 2006 Jan; 45(3):1043-53. PubMed ID: 16411781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relaxin family peptide receptors Rxfp1 and Rxfp2: mapping of the mRNA and protein distribution in the reproductive tract of the male rat.
    Filonzi M; Cardoso LC; Pimenta MT; Queiróz DB; Avellar MC; Porto CS; Lazari MF
    Reprod Biol Endocrinol; 2007 Jul; 5():29. PubMed ID: 17623071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.